Klimek, Ludger
Bachert, Claus
Pfaar, Oliver
Becker, Sven
Bieber, Thomas
Brehler, Randolf
Buhl, Roland
Casper, Ingrid
Chaker, Adam
Czech, Wolfgang
Fischer, Jörg
Fuchs, Thomas
Gerstlauer, Michael
Hörmann, Karl
Jakob, Thilo
Jung, Kirsten
Kopp, Matthias V.
Mahler, Vera
Merk, Hans
Mülleneisen, Norbert
Nemat, Katja
Rabe, Uta
Ring, Johannes
Saloga, Joachim
Schlenter, Wolfgang
Schmidt-Weber, Carsten
Seyfarth, Holger
Sperl, Annette
Spindler, Thomas
Staubach, Petra
Strieth, Sebastian
Treudler, Regina
Vogelberg, Christian
Wallrafen, Andrea
Wehrmann, Wolfgang
Wrede, Holger
Zuberbier, Torsten
Bedbrook, Anna
Canonica, Giorgio W.
Cardona, Victoria
Casale, Thomas B.
Czarlewski, Wienczylawa
Fokkens, Wytske J.
Hamelmann, Eckard
Hellings, Peter W.
Jutel, Marek
Larenas-Linnemann, Désirée
Mullol, Joaquim
Papadopoulos, Nikolaos G.
Toppila-Salmi, Sanna
Werfel, Thomas
Bousquet, Jean
Article History
First Online: 22 October 2019
Change Date: 12 February 2020
Change Type: Correction
Change Date: 12 February 2020
Change Type: Correction
Change Details: <Emphasis Type="Bold">Correction to:</Emphasis><Emphasis Type="Bold">Allergo J Int 2019</Emphasis><ExternalRef><RefSource>https://doi.org/10.1007/s40629-019-00110-9</RefSource><RefTarget Address="10.1007/s40629-019-00110-9" TargetType="DOI"/></ExternalRef>Affiliation and disclaimer have been misrepresented and are hereby corrected:Vera Mahler:<Emphasis Type="Italic">Affiliation:</Emphasis> Med. Faculty, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg, Germany.<Emphasis Type="Italic">Disclaimer:</Emphasis> The views expressed in this …
Change Details: <b>Correction to:</b>
Conflict of interest
: C. Bachert reports personal fees from Mylan, Stallergenes and ALK, outside the submitted work. S. Becker reports personal fees from ALK, Allergopharma, HAL Allergy, Bencard Allergy, Sanofi-Genzyme, Thermo Fisher Scientific and B.R.A.I.N AG, grants and personal fees from PARI GmbH, outside the submitted work. T. Bieber reports personal fees from Sanofi, Novartis, AbbVIe, Galderma, Pfizer, Lilly, Kymab, outside the submitted work. J. Bousquet reports personal fees from Chiesi, Cipla, Hikma, Menarini, Mundipharma, Mylan, Novartis, Purina, Sanofi-Aventis, Takeda, Teva, Uriach, other from KYomed-Innov, outside the submitted work. R. Brehler reports personal fees form Berufsgenossenschaften, Gerichten, ÄK Nordwürttemberg, ÄK Westfalen-Lippe, ALK, Allergopharma, Allmiral, Apothekerkammer, Astra Zeneca, Bencard, DPC, Gesellschaft zur Förderung der Dermatologischen Forschung und Fortbildung, GSK, HAL, HNO-Gesellschaft, Leti, Novartis, Pohl-Boskamp, Pfleger, Phadia, Update GmbH, Stallergenes, grants from Biotechtools, Genentech, Novartis, Bencard, HAL, AstraZeneca, ALK, outside the submitted work. V. Cardona reports personal fees from ALK, Allergopharma, Allergy Therapeutics, Diater, LETI, Thermofisher and Stallergenes, outside the submitted work. J. Mullol reports personal fees from ALK-Abelló, Sanofi-Genzyme & Regeneron, Menarini Group, MSD, Mitsubishi-Tanabe, Novartis, UCB Pharma, GENENTECH - Roche, grants and personal fees from URIACH Group, MYLAN-MEDA Pharma, outside the submitted work. H.F. Merk reports personal fees from MEDA, Grünenthal and Coty, outside the submitted work. T. Jakob reports grants, personal fees and non-financial support from Novartis, ALK Abello, personal fees and non-financial support from Bencard/Allergy Therapeutics, personal fees from Allergopharma, Thermo Fisher Scientific and Celgene, outside the submitted work. M. Jutel reports personal fees from ALK-Abello, Allergopharma, Stallergenes, Anergis, Allergy Therapeutics, Circassia, Leti, Biomay, HAL, during the conduct of the study; personal fees from Astra-Zeneka, GSK, Novartis, Teva, Vectura, UCB, Takeda, Roche, Janssen, Medimmune and Chiesi, outside the submitted work. L. Klimek reports grants and personal fees from ALK Abelló, Novartis, Allergopharma, Bionorica, GSK and Lofarma; personal fees from Boehringer Ingelheim and MEDA, grants from Biomay, HAL, LETI, Roxall, Bencard, outside the submitted work. P. Hellings reports grants and personal fees from Mylan, during the conduct of the study; personal fees from Sanofi, Allergopharma and Stallergenes, outside the submitted work. J. Saloga reports personal fees from ALK-Abelló, Novartis Pharma and Thermo Fisher, outside the submitted work. C. Schmidt-Weber reports grants from DFG, DZL, during the conduct of the study; personal fees and/or grants from Bencard, Allergopharma, Leti Pharma, outside the submitted work. In addition, he has a patent on AIT biomarker. S. Strieth reports grants from Deutsche Forschungsgemeinschaft (DFG), Stiftung Tumorforschung Kopf-Hals, grants Andreas Fahl Medizintechnik-Vertrieb, Atos Medical, Tracoe Medical, Heimomed Heinze, Bromepithetik, Fresenius Kabi and non-financial support from MED-EL AG, personal fees from Auris Medical, Merck Serono, Otonomy, Inc., Nordmark Arzneimittel, Sonofi Genzyme, ALK-Abelló Arzneimittel, outside the submitted work. R. Treudler reports grants and personal fees from Sanofi-Genzyme, personal fees from ALK-Abello, Takeda, Novartis, grants from Hautnetz Leipzig, other from Fraunhofer-IZI Leipzig, outside the submitted work. S. Toppila-Salmi reports consultancy for Mylan Laboratories Ltd, ERT Ltd, Roche Products Ltd, outside the submitted work. C. Vogelberg reports grants and/or personal fees from ALK Abello, Allergopharma, AstraZeneca, Boehringer Ingelheim, Bencard Allergy, DBV Technologies, Novartis Pharma and Sanofi Avensis, outside the submitted work. A. Bedbrook, R. Buhl, G.W. Canonica, T.B. Casale, I. Casper, A. Chaker, W. Czarlewski, W. Czech, J. Fischer, K. Nemat, N.G. Papadopoulos, O. Pfaar, U. Rabe, M. Kopp, D. Larenas-Linnemann, V. Mahler, N. Mülleneisen, K. Hörmann, K. Jung, W. Fokkens, T. Fuchs, M. Gerstlauer, E. Hamelmann, J. Ring, W. Schlenter, H. Seyfarth, A. Sperl, T. Spindler, P. Staubach, A. Wallrafen, W. Wehrmann, T. Werfel, H. Wrede and T. Zuberbier declare that they have no competing interests.